332099-36-2 Usage
General Description
3-Bromo-4(H)-thieno[3,2-b]pyrrole-5-carboxylic acid is a chemical compound that falls under the category of organic compounds known as pyrroles and thiophenes. Pyrroles are aromatic compounds containing a five-membered unsaturated ring of four carbon atoms and one nitrogen atom while, thiophenes are compounds containing a thiophene ring, which is a five-membered aromatic ring made up of four carbon atoms and one sulfur atom. The precise properties of 3-Bromo-4(H)-thieno[3,2-b]pyrrole-5-carboxylic acid, such as its molecular weight, boiling and melting points, and solubility, are dependent on its specific molecular structure. 3-BROMO-4(H)-THIENO[3,2-B]PYRROLE-5-CARBOXYLICACID can be used in chemical research and might be an intermediate in the synthesis of more complex chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 332099-36-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,2,0,9 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 332099-36:
(8*3)+(7*3)+(6*2)+(5*0)+(4*9)+(3*9)+(2*3)+(1*6)=132
132 % 10 = 2
So 332099-36-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrNO2S/c8-3-2-12-5-1-4(7(10)11)9-6(3)5/h1-2,9H,(H,10,11)
332099-36-2Relevant articles and documents
Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues
Parmentier, Jean-Gilles,Portevin, Bernard,Golsteyn, Roy M.,Pierré, Alain,Hickman, John,Gloanec, Philippe,De Nanteuil, Guillaume
scheme or table, p. 841 - 844 (2009/08/07)
A series of thieno[3,2-b]pyrroloazepinones derivatives related to Hymenialdisine were prepared and tested for CHK1 inhibitory activity. Nanomolar inhibitions were achieved when electron-withdrawing substituents were introduced at position 3 of the thiophene ring.
USE OF FUSED PYRROLE CARBOXYLIC ACIDS FOR THE TREATMENT OF NEURODEGENERATIVE AND PSYCHIATRIC DISEASES AS D-AMINO ACID OXIDASE INHIBITORS
-
Page/Page column 18, (2008/06/13)
The present invention provides the use of fused pyrrole carboxylic acids of formula (I) for the manufacture of a medicament to inhibit D-amino acid oxidase, particularly for the treatment of neurodegenerative and psychiatric disorders or diseases; certain
Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
-
, (2008/06/13)
This invention relates to compounds of Formula I or stereoisomers, pharmaceutically acceptable salts or prodrugs thereof or a pharmaceutically acceptable salts of the prodrugs. This invention also relates to pharmaceutical compositions comprising a compou
